secwatch / observer

Earnings Releases

Quarterly and annual results disclosed under 8-K Item 2.02.

8-K items 2.02 JSON
Aimco OP L.P.

Aimco OP L.P. reported the quarter ended March 31, 2024 results: EPS $(0.07) for the quarter ended March 31, 2024.

“Net loss attributable to common stockholders per share, on a fully dilutive basis, was $(0.07) for the quarter ended March 31, 2024”
SKYT SkyWater Technology, Inc

SkyWater Technology, Inc reported first quarter 2024 ended March 31, 2024 results: revenue $79.6 million, net income Net loss to shareholders of $5.7 million, or $0.12 per share on a GAAP basis, EPS $0.12 per share on a GAAP basis.

“partner, today announced financial results for the first quarter 2024 ended March 31, 2024. Financial Highlights for Q1 2024: • Revenue increased 20% year-over-year to a record $79.6 million. • Gross margin decreased to 16.3% on a GAAP basis, compared to 24.9% in Q1 2023, and decreased to 16.9% on a non-GAAP basis, compared to 25.7% in Q1 2023. • Net loss to”
RDW Redwire Corp

Redwire Corp reported full year ended December 31, 2024 results: revenue $300 million. Guidance reaffirmed.

“For the full year ended December 31, 2024, Redwire affirms that it is forecasting revenues of $300 million.”
RDW Redwire Corp

Redwire Corp reported first quarter ended March 31, 2024 results: revenue $87.8 million, net income $(8.1) million.

“Revenues for the first quarter of 2024 increased 52.4% year-over-year to $87.8 million Net Loss was $(8.1) million”
TARS Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. reported first quarter ended March 31, 2024 results: revenue $27.6 million, net income $35.7 million, EPS $(1.01).

“million at the close, providing approximately $40 million net after the repayment of the previous facility First Quarter 2024 Financial Results • First quarter revenues were $27.6 million, driven primarily by $24.7 million in net product sales, and $2.9 million in license fees and collaboration revenue. • Cost of sales were $1.7 million, due to manufacturing”
TNGX Tango Therapeutics, Inc.

Tango Therapeutics, Inc. reported the first quarter ended March 31, 2024 results: revenue $6.5 million, net income $37.9 million, EPS $0.35 per share.

“held $343.6 million in cash, cash equivalents and marketable securities, which the Company expects to be sufficient to fund operations into late 2026. Collaboration revenue was $6.5 million for the three months ended March 31, 2024, compared to $5.8 million for the same period in 2023. Research costs incurred under the collaboration were similar during each of the”
OPFI OppFi Inc.

OppFi Inc. reported the first quarter ended March 31, 2024 results: revenue $127.3 million, net income $10.1 million, EPS $0.10. Guidance raised.

“OppFi Exceeds First Quarter 2024 Guidance, Raises Full-Year Earnings Outlook Total revenue increased 5.8% year over year to $127.3 million Net income increased 157.8% year over year to $10.1 million Adjusted net income increased 127.8% year over year to $8.8 million Basic and Diluted EPS of $0.29 and $0.10, respectively”
JANX Janux Therapeutics, Inc.

Janux Therapeutics, Inc. reported first quarter ended March 31, 2024 results: net income Net loss of $14.8 million.

“Janux Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2024.”
Markforged Holding Corp

Markforged Holding Corp reported the first quarter ended March 31, 2024 results: revenue $20.5 million.

“of need, today announced its financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Compared To First Quarter 2023 • Revenue was $20.5 million compared to $24.1 million. • Gross margin was 49.3% compared to 48.1%. • Non-GAAP gross margin was 51.3% compared to 49.3%. • Operating expenses were $47.2 million, inclusive of”
CMPS COMPASS Pathways plc

COMPASS Pathways plc reported three months ended March 31, 2024 results: net income $35.2 million, EPS $0.55 loss per share. Guidance initiated.

“Net loss for the three months ended March 31, 2024, was $35.2 million, or $0.55 loss per share (including non-cash share-based compensation expense of $5.1 million), compared with $24.2 million, or $0.57 loss per share, during the same period in 2023 (including non-cash-share-based compensation expense of $4.1 million).”
LENZ LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc. reported financial results for the quarter ended March 31, 2024.

“On May 8, 2024, LENZ Therapeutics, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2024.”
TPL Texas Pacific Land Corp

Texas Pacific Land Corp reported first quarter of 2024 results: revenue $174.1 million, net income $114.4 million, EPS $4.97 per share (diluted).

“of 10,000 barrels of produced water per day. • Three-for-one stock split effective March 26, 2024 • Net income of $114.4 million, or $4.97 per share (diluted) • Revenues of $174.1 million, including record water segment revenues of $62.7 million • Adjusted EBITDA (1) of $152.0 million • Free cash flow (1) of $114.5 million • Royalty production of 24.8 thousand”
ALIT Alight, Inc. / Delaware

Alight, Inc. / Delaware reported first quarter ended March 31, 2024 results: revenue $559 million, EPS $(0.22).

“First Quarter 2024 Continuing Operations Highlights (all comparisons are relative to first quarter 2023) • Revenue decreased 4.6% to $559 million • Business Process as a Service (BPaaS) revenue grew 20.6% to $117 million, representing 20.9% of total revenue • Gross profit of $182 million and gross profit margin of 32.6%, compared to $187 million and 31.9% in the prior year period, respectively, and adjusted gross profit of $208 million and adjusted gross profit margin of 37.2%, compared to $211 million and 36.0%, in the prior year period, respectively • Net loss increased by $37 million over the prior year period to $121 million driven primarily by a $43 million increase in non-cash charges • Adjusted EBITDA increased by $4 million over the prior year period to $116 million • Diluted earnings (loss) per share of $(0.22) compared to $(0.16) in the prior year period, and adjusted diluted e”
Blue Owl Capital Corp III

Blue Owl Capital Corp III reported financial results for first quarter ended March 31, 2024.

“On May 8, 2024, Blue Owl Capital Corporation III (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024.”
DSGN Design Therapeutics, Inc.

Design Therapeutics, Inc. reported the quarter ended March 31, 2024 results: net income $11.1 million.

“Net loss was $11.1 million for the quarter ended March 31, 2024.”
VERX Vertex, Inc.

Vertex, Inc. reported first quarter ended March 31, 2024 results: revenue Total revenues of $156.8 million, net income Net income of $2.7 million, EPS Net income per basic and diluted Class A and Class B shares of $0.02.

“recent successful convertible debt offering, give me confidence in our ability to continue to grow shareholder value.” ​ First Quarter 2024 Financial Results ● Total revenues of $156.8 million, up 18.1% year-over-year. ● Software subscription revenues of $131.8 million, up 18.8% year-over-year. ● Cloud revenues of $61.8 million, up 28.3% year-over-year. ● Annual”
EHAB Enhabit, Inc.

Enhabit, Inc. reported the quarter ended March 31, 2024 results: revenue $262.4 million, net income $0.2 million, EPS $0.01. Guidance reaffirmed.

“in both the first quarter of 2024 and 2023. We are confident we are taking the right steps to drive future growth.” QUARTERLY PERFORMANCE - CONSOLIDATED • Net service revenue of $262.4 million • Net income attributable to Enhabit, Inc. of $0.2 million • Adjusted EBITDA of $25.3 million • Earnings per share of $0.01 • Adjusted earnings per share of $0.07 RECENT COMPANY”
CTEV Claritev Corp

Claritev Corp reported first quarter ended March 31, 2024 results: revenue $234.5 million, net income Net loss of $539.7 million. Guidance reaffirmed.

“MultiPlan Reports First Quarter 2024 Results – Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million”
HPK HighPeak Energy, Inc.

HighPeak Energy, Inc. reported the first quarter ended March 31, 2024 results: net income $6.4 million, EPS $0.05 per diluted share.

“HighPeak reported net income of $6.4 million for the first quarter of 2024, or $0.05 per diluted share”
XPER Xperi Inc.

Xperi Inc. reported the first quarter ended March 31, 2024 results: revenue $ 118.8, net income $ (13.4 ), EPS $ (0.29 ).

“set the stage for significant long-term revenue growth and margin expansion.” Financial Highlights GAAP Highlights ($ millions, except per share data) Q1 FY24 Q1 FY23 Revenue $ 118.8 $ 126.8 2 GAAP Operating Loss $ (32.3 ) $ (33.6 ) GAAP Net Loss $ (13.4 ) $ (32.9 ) GAAP Loss per Share attributable to Xperi $ (0.29 ) $ (0.76 ) Non-GAAP 1 Highlights ($”
REYN Reynolds Consumer Products Inc.

Reynolds Consumer Products Inc. reported first quarter ended March 31, 2024 results: revenue $833 million, net income $49 million, EPS $0.23. Guidance raised.

“Inc. (“RCP” or the “Company”) (Nasdaq: REYN) today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights • Net Revenues of $833 million vs. $874 million in Q1 2023 ◦ Retail Net Revenues decreased 3% to $794 million, at the high end of Company expectations ◦ Non-retail Net Revenues decreased 32% to $39 million, as”
PRCH Porch Group, Inc.

Porch Group, Inc. updated its first quarter ended March 31, 2024 guidance (raised).

“On May 8, 2024, Porch Group, Inc. (the “Company”) issued an earnings release announcing financial results for its first quarter ended March 31, 2024.”
HOOD Robinhood Markets, Inc.

Robinhood Markets, Inc. reported the first quarter of 2024, which ended March 31, 2024 results: revenue $618 million, net income $157 million, EPS $0.18. Guidance reaffirmed.

“Robinhood Reports First Quarter 2024 Results Record Revenues of $618 million, up 40% year-over-year and Record GAAP Diluted EPS of $0.18”
AZEK Co Inc.

AZEK Co Inc. reported the six months ended March 31, 2024 results: revenue Consolidated Net Sales of $658.9 million, net income Net income in the range of $74 to $75 million. Guidance raised.

“For the six months ended March 31, 2024, AZEK expects to report results, including: • Consolidated Net Sales of $658.9 million, representing 11% year-over-year growth o Adjusted Net Sales excluding results for Vycom increased 19% year-over-year • Net income in the range of $74 to $75 million • Net profit margin in the range of 11.2% to 11.4% • Adjusted EBITDA in the range of $167 to $169 million • Adjusted EBITDA margin in the range of 25.3% to 25.6%”
AZEK Co Inc.

AZEK Co Inc. reported the three months ended March 31, 2024 results: revenue Consolidated Net Sales of $418.4 million. Guidance raised.

“Growth and Material Conversion PRELIMINARY FINANCIAL RESULTS For the three months ended March 31, 2024, AZEK expects to report results, including: • Consolidated Net Sales of $418.4 million, representing 11% year-over-year growth o Adjusted Net Sales excluding results for Vycom increased 17% year-over-year • Residential Segment Net Sales of $402.5 million,”
LVLU Lulu's Fashion Lounge Holdings, Inc.

Lulu's Fashion Lounge Holdings, Inc. reported the first quarter ended March 31, 2024 results: revenue $77.3 million, net income Net loss of $5.7 million, EPS $(0.15).

“our opportunities to return to growth as we continue to build upon our operational efficiency, innovation, and product offering." First Quarter 2024 Highlights: ● Net revenue of $77.3 million, a decrease of 15% compared to $91.0 million in the same period last year, driven by a 17% decrease in Total Orders Placed with higher return rates, offset by higher Average”
SANA Sana Biotechnology, Inc.

Sana Biotechnology, Inc. reported financial results for the quarter and year ended March 31, 2024.

“On May 8, 2024, Sana Biotechnology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended March 31, 2024.”
ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc. reported the three months ended March 31, 2024 results: revenue $38.0 million.

“For the three months ended March 31, 2024, revenues were $38.0 million compared with $80.3 million for the three months ended March 31, 2023.”
KGS Kodiak Gas Services, Inc.

Kodiak Gas Services, Inc. reported the quarter ended March 31, 2024 results: revenue $215.5 million, net income $30.2 million. Guidance raised.

“any contribution from the Company’s acquisition of CSI Compressco (“CSI”) that closed on April 1, 2024. First Quarter 2024 Highlights • Total revenues for the quarter were $215.5 million compared to $190.1 million in the first quarter of 2023 • Core Compression Operations segment revenues increased 2% sequentially and 9% over last year’s first quarter •”
CLVT CLARIVATE PLC

CLARIVATE PLC updated its the first quarter ended March 31, 2024 guidance (reaffirmed).

“On May 8, 2024, Clarivate Plc (the “Company”) issued a press release announcing earnings for the first quarter ended March 31, 2024.”
ERAS Erasca, Inc.

Erasca, Inc. reported the fiscal quarter ended March 31, 2024 results: net income $35.0 million, EPS $(0.23) per basic and diluted share.

“Net loss was $35.0 million, or $(0.23) per basic and diluted share, for the quarter ended March 31, 2024”
ALTG ALTA EQUIPMENT GROUP INC.

ALTA EQUIPMENT GROUP INC. reported the first quarter ended March 31, 2024 results: revenue $441.6 million, net income Net loss available to common stockholders of $(12.7) million, EPS Basic and diluted net loss per share of $(0.38). Guidance reaffirmed.

“Exhibit 99.1 Alta Equipment Group Announces First Quarter 2024 Financial Results First Quarter Financial Highlights: • Total revenues increased $20.9 million year over year to $441.6 million • Construction and Material Handling revenues of $255.6 million and $174.3 million, respectively • Product support revenues increased 6.5% year over year with Parts sales”
MIRM Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. reported the quarter ended March 31, 2024 results: revenue $69.2 million. Guidance reaffirmed.

“such filing. --- EX-99.1 (EX-99.1) --- Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update • First quarter 2024 total revenue of $69.2 million, on track to achieve full-year guidance of $310 to $320 million • FDA approval of LIVMARLI for cholestatic pruritus in PFIC patients achieved in March • Volixibat VISTAS and”
STE STERIS plc

STERIS plc reported fiscal 2024 full year ended March 31, 2024 results: revenue $5.5 billion, net income $3.81 per diluted share, EPS $3.81 per diluted share.

“Total revenue for fiscal 2024 increased 12% to $5.5 billion compared with $5.0 billion in fiscal 2023.”
STE STERIS plc

STERIS plc reported fiscal 2024 fourth quarter ended March 31, 2024 results: revenue $1.5 billion, net income ($0.01) per diluted share, EPS ($0.01) per diluted share.

“Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billion in the fourth quarter of fiscal 2023.”
FOXA Fox Corp

Fox Corp reported the quarter ended March 31, 2024 results: revenue $3.45 billion, net income $704 million, EPS $1.40 per share.

“FOX REPORTS THIRD QUARTER FISCAL 2024 REVENUES OF $3.45 BILLION, NET INCOME OF $704 MILLION, AND ADJUSTED EBITDA OF $891 MILLION”
ASLE AerSale Corp

AerSale Corp reported the fiscal quarter ended March 31, 2024 results: revenue $90.5 million, net income $6.3 million.

“set forth by specific reference in such a filing. ​ --- EX-99.1 (EX-99.1) --- AerSale Reports First Quarter 2024 Results ​ First Quarter 2024 Highlights ● Revenue of $90.5 million versus $78.3 million in the prior year period. ● GAAP net income of $6.3 million versus $5 thousand in the prior year period. ● Adjusted Net Income 1 of $5.5 million versus $3.3”
BKSY BlackSky Technology Inc.

BlackSky Technology Inc. reported first quarter ended March 31, 2024 results: revenue $24.2 million, net income $15.8 million.

“First Quarter Financial Highlights: • Revenue of $24.2 million, up 32% from the prior year quarter • Imagery & software analytical services revenue grew 13% over the prior year quarter • Cost of sales, as a percent of revenue, related to imagery & software analytical services improved to 19% from 23% in the prior year quarter “Strong execution combined with growing global demand for our space-based intelligence solutions drove a 32% increase in first quarter revenues versus the prior year period,” said Brian E.”
KLDiscovery Inc.

KLDiscovery Inc. reported the three months ended March 31, 2024 results: revenue $80.2 million, net income $(16.9) million.

“provider of electronic discovery, information governance and data recovery technology solutions, announced today that revenue for the first quarter ended March 31, 2024, was $80.2 million compared to $90.7 million in the first quarter of 2023. Net loss for the first quarter of 2024 was $(16.9) million compared to $(4.5) million in the first quarter of 2023. EBITDA”
APP AppLovin Corp

AppLovin Corp reported first quarter ended March 31, 2024 results: revenue $1.06 billion, net income $236 million. Guidance initiated.

“In the first quarter, we generated revenue of $1.06 billion (+48% yr/yr), net income of $236 million at a net margin of 22%, and Adjusted EBITDA of $549 million (+101% yr/yr) at an Adjusted EBITDA margin of 52%.”
OLMA Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. reported first quarter ended March 31, 2024 results: net income Net loss for the quarter ended March 31, 2024, was $31.0 million.

“On May 8, 2024, Olema Pharmaceuticals, Inc. (the “Company”) reported its financial results for the quarter ended March 31, 2024.”
CWBHF Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $12.1, net income $(9.7), EPS $(0.06).

“The following table sets forth selected financial information for the periods indicated. Three Months Ended, March 31, U.S. $ millions, except per share data 2024 2023 Revenue $12.1 $17.0 Cost of goods sold 5.2 7.1 Gross profit 6.9 9.9 Selling, general and administrative expenses 15.3 17.5 Operating loss (8.4) (7.6) Other income (expense), net 0.6 (0.7)”
NFE New Fortress Energy Inc.

New Fortress Energy Inc. reported the first quarter of 2024 results: revenue $690.3, net income $56.7, EPS $0.26.

“of June 15, 2024 and a payment date of June 27, 2024. Financial Detail Three Months Ended (in millions) March 31, 2023 December 31, 2023 March 31, 2024 Revenues $ 579.1 $ 758.4 $ 690.3 Net income $ 151.6 $ 214.9 $ 56.7 Diluted EPS $ 0.71 $ 1.06 $ 0.26 Adjusted net income (6) $ 187.6 $ 206.6 $ 138.4 Adjusted EPS (2) $ 0.90 $ 1.01 $ 0.67 Terminals and”
ELAN Elanco Animal Health Inc

Elanco Animal Health Inc reported the first quarter of 2024 results: revenue $1,205 million, net income $32 million, EPS $0.06. Guidance reaffirmed.

“Elanco Animal Health Reports First Quarter 2024 Results • First Quarter 2024 Financial Results ◦ Revenue of $1,205 million ◦ Reported Net income of $32 million, Adjusted Net income of $167 million ◦ Adjusted EBITDA of $294 million, or 24.4% of Revenue ◦ Reported EPS of $0.06, Adjusted EPS of $0.34”
BXSL Blackstone Secured Lending Fund

Blackstone Secured Lending Fund reported financial results for first quarter ended March 31, 2024.

“On May 8, 2024, Blackstone Secured Lending Fund issued a press release and detailed presentation announcing its financial results for the first quarter ended March 31, 2024.”
SEER Seer, Inc.

Seer, Inc. reported the first quarter ended March 31, 2024 results: revenue $3.1 million. Guidance reaffirmed.

“commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights • Achieved revenue of $3.1 million for the first quarter of 2024 • Announced the expansion of the Seer Technology Access Center (STAC) program to Europe, providing researchers with end-to-end services from sample”
INBS INTELLIGENT BIO SOLUTIONS INC.

INTELLIGENT BIO SOLUTIONS INC. reported nine months ended March 31, 2024 results: revenue $2.38 million, net income $7.37 million.

“Total revenue for the nine months ended March 2024 was $2.38 million, an increase of 193% compared to the same period the year prior.”
INBS INTELLIGENT BIO SOLUTIONS INC.

INTELLIGENT BIO SOLUTIONS INC. reported fiscal third quarter ended March 31, 2024 results: revenue $0.82 million, net income $2.98 million.

“Total revenues for the fiscal third quarter were $0.82 million, an increase of 80% compared to the same period the year prior.”
RCUS Arcus Biosciences, Inc.

Arcus Biosciences, Inc. reported the first quarter ended March 31, 2024 results: revenue $145 million.

“to fund operations into 2027. Cash, cash equivalents and marketable securities are expected to be between $870 million and $920 million at the end of 2024. • Revenues were $145 million for the first quarter 2024, compared to $25 million for the same period in 2023. In the first quarter 2024, Arcus recognized $135 million in license and development services”
Jamf Holding Corp.

Jamf Holding Corp. reported the quarter ended March 31, 2024 results: revenue $152.1 million.

“Jamf Announces First Quarter 2024 Financial Results • Q1 total revenue year-over-year growth of 15% to $152.1 million”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.